tiprankstipranks
Advertisement
Advertisement
Options Volatility and Implied Earnings Moves Today, March 25, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 25, 2026
4d ago
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
6d ago
Is PGEN a Buy, Before Earnings?
Premium
Pre-Earnings
Is PGEN a Buy, Before Earnings?
22d ago
Precigen reports Q3 EPS ($1.06) vs. (9c) last year
PremiumThe FlyPrecigen reports Q3 EPS ($1.06) vs. (9c) last year
5M ago
PGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
Premium
Company Announcements
Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
5M ago
Buy Rating for Precigen: Strong Market Potential and Strategic Positioning of Papzimeos
PremiumRatingsBuy Rating for Precigen: Strong Market Potential and Strategic Positioning of Papzimeos
7M ago
Precigen price target raised to $8 from $6 at Citizens JMP
Premium
The Fly
Precigen price target raised to $8 from $6 at Citizens JMP
7M ago
Precigen Enters Commercial Supply Agreement with Catalent
Premium
Company Announcements
Precigen Enters Commercial Supply Agreement with Catalent
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100